Former President Biden Secures $10 Million Memoir Deal, Below Predecessors
Former President Joe Biden secured a $10 million deal for his presidential memoir. The advance is lower than recent Democratic presidents, and his health may affect the release timeline.
Overview
- Former President Joe Biden has sold his presidential memoir to the Hachette Book Group, securing a $10 million advance for the upcoming publication.
- This $10 million advance is notably lower than the book deals received by recent Democratic presidents, including Barack Obama's $60 million and Bill Clinton's $15 million.
- The deal for Biden's memoir was represented by Creative Artists Agency, though a specific publication date for the book has not yet been set by Hachette.
- The timeline for the memoir's release could potentially be affected by Former President Biden's aggressive prostate cancer diagnosis, as mentioned in reports.
- Unlike Former President Biden, Donald Trump broke with traditional post-presidency practice by not pursuing a memoir deal after leaving office.
Report issue
Read both sides in 5 minutes each day
Analysis
Analysis unavailable for this viewpoint.
Articles (3)
Center (0)
No articles found in the Center category
FAQ
Joe Biden's $10 million memoir deal is notably lower than the $60 million deal Barack Obama and the $15 million deal Bill Clinton received from their memoirs.
Joe Biden's aggressive prostate cancer diagnosis, which has metastasized to the bone, may affect the timeline for the memoir's release as his health could impact his ability to finalize the book.
Joe Biden has been treated for non-valvular atrial fibrillation, hyperlipidemia, gastroesophageal reflux, seasonal allergies, and more recently diagnosed with an aggressive form of prostate cancer with bone metastasis.
Yes, unlike Donald Trump who did not pursue a memoir deal after leaving office, Joe Biden secured a traditional memoir book deal represented by Creative Artists Agency with the Hachette Book Group.
Biden's prostate cancer is classified as aggressive and has spread to his bones, but it appears to be hormone-sensitive, allowing for effective management despite being generally considered advanced and incurable once metastasized.
History
- This story does not have any previous versions.